PlexusDx vs Cora Health: GLP-1 Pricing and Plan Terms Compared (2026)

Last reviewed: September 10, 2026 Last updated: September 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Cora Health offers lower per-month rates on every prepaid plan—quarterly, semiannual, and annual—for both compounded semaglutide and tirzepatide injection. The annual semaglutide plan costs $1,188 upfront ($99/month, prepaid) versus PlexusDx's six-month plan at $149/month; the annual tirzepatide plan costs $1,620 upfront ($135/month, prepaid) versus PlexusDx's six-month plan at $249/month. PlexusDx costs less only on month-to-month semaglutide ($189 versus Cora Health's $175 monthly rate) and offers oral-capsule and microdose options Cora Health does not carry. Both include consultation, medication, and shipping in the quoted price; neither charges a separate membership fee. The decision turns on upfront budget, commitment comfort, and medication preference.

At-a-glance comparison

Cora Health pricing captured September 4, 2026 from trycora.io/plans/. PlexusDx pricing captured July–September 2026. Prepaid figures are our calculation of the per-month rate; full upfront payment required.

Like-for-like pricing: month-to-month and prepaid plans

Cora Health and PlexusDx both publish transparent, all-inclusive pricing with no membership fee. Every quoted rate covers the provider visit, compounded medication, ongoing monitoring, and shipping. Both programs charge a flat rate regardless of dose, so escalation from 0.25 mg to 2.4 mg semaglutide or from 2.5 mg to 15 mg tirzepatide carries no additional cost.

Cora Health structures four billing options: monthly (billed each month), quarterly (three months prepaid), semiannual (six months prepaid), and annual (twelve months prepaid). PlexusDx offers month-to-month, three-month, and six-month plans; the three-month and six-month plans bill monthly at the discounted rate and do not require upfront payment in full.

Semaglutide injection

On a month-to-month basis, Cora Health charges $175 and PlexusDx charges $189—a $14/month advantage to Cora Health and a $168 difference over twelve months ($2,100 versus $2,268; our calculation).

Cora Health's quarterly prepaid plan costs $435 upfront and delivers three months of medication at $145/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx's three-month plan bills $169/month with no upfront lump sum. Over twelve months the quarterly-prepaid route costs $1,740 (four $435 payments; our calculation) versus PlexusDx's $2,028 (our calculation).

Cora Health's semiannual prepaid plan costs $720 upfront for six months at $120/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx's six-month plan bills $149/month with no upfront payment. Over twelve months the semiannual-prepaid route costs $1,440 (two $720 payments; our calculation) versus PlexusDx's $1,788 (our calculation).

Cora Health's annual prepaid plan costs $1,188 upfront for twelve months at $99/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx does not offer a twelve-month option. The annual Cora Health plan saves $600 over PlexusDx's six-month rate across one year (our calculation).

Tirzepatide injection

On a month-to-month basis, Cora Health charges $225 and PlexusDx charges $289—a $64/month advantage to Cora Health and a $768 difference over twelve months ($2,700 versus $3,468; our calculation).

Cora Health's quarterly prepaid plan costs $597 upfront for three months at $199/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx's three-month plan bills $269/month. Over twelve months the quarterly-prepaid route costs $2,388 (four $597 payments; our calculation) versus PlexusDx's $3,228 (our calculation).

Cora Health's semiannual prepaid plan costs $1,050 upfront for six months at $175/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx's six-month plan bills $249/month. Over twelve months the semiannual-prepaid route costs $2,100 (two $1,050 payments; our calculation) versus PlexusDx's $2,988 (our calculation).

Cora Health's annual prepaid plan costs $1,620 upfront for twelve months at $135/month (our calculation, labeled as prepaid; captured September 4, 2026). PlexusDx does not offer a twelve-month option. The annual Cora Health plan saves $1,368 over PlexusDx's six-month rate across one year (our calculation).

What Cora Health includes and where documentation gaps remain

Cora Health's published pricing (captured September 4, 2026 from trycora.io/plans/) states that every plan includes consultation, medication, shipping, and monitoring. The site notes a flat-by-dose policy, meaning escalation to higher doses does not trigger a price increase—consistent with PlexusDx's same-price-every-dose approach.

Two questions remain unverified in the indexed evidence: whether the annual supply ships at once or in monthly installments, and the cancellation or refund terms for prepaid plans. Prospective members committing $1,188 or $1,620 upfront should confirm delivery logistics and early-termination policy at intake or checkout.

Cora Health maintains a Trustpilot profile at trustpilot.com/review/trycora.io (captured September 4, 2026), but no rating, review volume, or attributable feedback was captured in the indexed pass. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

What PlexusDx includes and where it differs

PlexusDx offers five compounded GLP-1 formulations: semaglutide injection, tirzepatide injection, semaglutide oral capsules, tirzepatide oral capsules, and a microdose semaglutide injection protocol for maintenance or slower titration. Cora Health carries only the two injection options.

PlexusDx's multi-month plans (three-month and six-month) bill monthly at the discounted rate rather than requiring the full term upfront. A member on the six-month semaglutide plan pays $149 each month for six months; if they discontinue after month four, they pay only for the four months used. Cora Health's prepaid plans lock in the discount but require full payment at the start of the term.

Every PlexusDx price includes the provider visit, prescription, compounded medication, shipping, and ongoing access to the care team. No membership fee, no per-dose surcharge, no separate consultation or lab fee appears on the invoice. Dose escalation—for example, moving from 0.5 mg to 1 mg semaglutide weekly—occurs at the same monthly rate.

Choose Cora Health if…

• You are committed to twelve months of treatment and have $1,188 (semaglutide) or $1,620 (tirzepatide) available upfront; the annual prepaid plans deliver the lowest per-month cost in this comparison.
• You prefer a six-month commitment and can prepay $720 (semaglutide) or $1,050 (tirzepatide) at once; the semiannual rate undercuts PlexusDx's six-month monthly-billed option by $29/month (semaglutide) or $74/month (tirzepatide).
• You are certain you want injection-only therapy; Cora Health does not offer oral-capsule or microdose alternatives, so the decision tree is simpler.
• You value the security of a locked-in rate for a full year and do not anticipate needing to pause or switch providers mid-term.

Choose PlexusDx if…

• You prefer month-to-month flexibility with no upfront lump sum; PlexusDx's three-month and six-month plans bill monthly, so you pay only for the time you use.
• You want access to oral-capsule semaglutide ($289/month MTM) or tirzepatide ($349/month MTM) as an alternative to injection, or you are interested in the microdose maintenance protocol ($129/month MTM).
• You are considering semaglutide on a true month-to-month basis and want the lower rate; PlexusDx charges $189 versus Cora Health's $175, but the $14 difference may be acceptable in exchange for the broader medication menu and flexible billing.
• You value the transparency of an established Trustpilot rating (4.3 stars, 83% four stars or higher) when evaluating service quality and support responsiveness.
• You anticipate dose adjustments, side-effect management, or the possibility of switching compounds mid-treatment; PlexusDx's five-option catalog and monthly billing reduce the friction and financial risk of changing course.

Methodology and freshness

This comparison draws on Cora Health's published plan page (trycora.io/plans/, captured September 4, 2026), PlexusDx product pages (captured July 17–23, 2026 and confirmed September 2026), and Trustpilot profiles for both brands (Cora Health captured September 4, 2026; PlexusDx captured September 9, 2026). Prepaid per-month rates—for example, Cora Health's $99/month semaglutide annual rate—are our calculation of the total upfront cost divided by the number of months; the label "prepaid" or "upfront" appears wherever such figures are cited. Twelve-month totals (e.g., $2,100, $1,788) are our calculation: monthly rate × 12 or prepaid lump sum × billing frequency. No promotional codes, first-month discounts, or referral credits were captured for either provider; the rates shown reflect standard, ongoing pricing. All figures are subject to change; confirm at checkout.

Frequently Asked Questions

Does Cora Health's annual plan ship all twelve months of medication at once?

The indexed evidence does not specify whether the $1,188 semaglutide or $1,620 tirzepatide annual prepayment delivers a year's supply in a single shipment or in monthly installments. Confirm delivery logistics and storage requirements during intake if you select the annual option.

Can I cancel a Cora Health prepaid plan mid-term and receive a prorated refund?

Cancellation and refund terms for Cora Health's quarterly, semiannual, and annual plans were not documented in the sources indexed September 4, 2026. Request the full terms of service and refund policy before committing funds to a multi-month prepaid plan.

Does PlexusDx require upfront payment for the three-month or six-month plans?

No. PlexusDx's three-month and six-month plans bill monthly at the discounted rate. A member on the six-month semaglutide plan pays $149 each month; if they stop after four months, they pay only for those four months.

Which provider offers a lower rate for tirzepatide on a month-to-month basis?

Cora Health charges $225/month for tirzepatide injection on the monthly plan; PlexusDx charges $289/month. Cora Health holds a $64/month advantage on true month-to-month billing for tirzepatide, amounting to $768 over twelve months (our calculation).

Does either program charge extra when my dose increases?

No. Both Cora Health and PlexusDx publish flat-by-dose pricing. Escalating from 0.5 mg to 1 mg semaglutide weekly, or from 5 mg to 10 mg tirzepatide weekly, does not change the monthly cost on either platform.

Sources

• Cora Health Plans & Pricing – trycora.io/plans/ (accessed September 4, 2026)
• Cora Health Trustpilot Profile – trustpilot.com/review/trycora.io (accessed September 4, 2026)
• PlexusDx Product Pages – plexusdx.com (accessed July 17–23, 2026; confirmed September 2026)
• PlexusDx Trustpilot Profile – trustpilot.com/review/plexusdx.com (accessed September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.